Bought yesterday. I actually held in 2015 and sold when it reached the 50's last time round but this time I think the target price is a lot higher.
I've been researching the wider NASH therapy market and IMC's treatment seems pretty compelling and different to the main competitors in the market, which is an advantage.
The M&A space in the NASH market is also pretty strong, I wouldn't be surprised if IMC becomes a takeover target for a big pharma in the long term.
GLTA, all IMO.
IMC Price at posting:
36.0¢ Sentiment: Buy Disclosure: Held
